Connect
MJA
MJA

Tissue plasminogen activator for acute ischaemic stroke

Gino J Toncich
Med J Aust 2008; 188 (8): 489.
Published online: 21 April 2008

To the Editor: The assertion of Davis and Batmanian and their colleagues that thrombolytic treatment for ischaemic stroke is reasonably safe and highly effective1,2 is not supported by the primary randomised trials of its use.3

  • Gino J Toncich

  • Emergency Department, Royal Melbourne Hospital, Melbourne, VIC.

Correspondence: gino.toncich@mh.org.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.